Australian, Taiwan firms ink JV for China’s senior health market

BRISBANE – Healthcare provider Tunstall Australasia has entered an exclusive connected health and care distribution agreement with the Taiwan health group, Revis Biotech, to deliver tailored solutions for China’s ageing population.

Tunstall’s Managing Dircetor, Lyn Davies, said the company had rekindled its long-term business relationship with Revlis while on a trade mission to China in November last year. They had originally worked together in 2006.

Revlis Biotech’s Chief Operating Officer, Martin Chang, says the new venture has potential to improve the lives of thousands of Chinese seniors.

“We aim to reach 32,000 connected health patients and 16,000 connected care clients by 2019,” he said. “This is the first people-centred, integrated healthcare service of its kind in China, and one that the aged care market greatly needs.”

Offering in-home emergency alarm monitoring and remote chronic disease management, the new service will enable seniors to stay out of hospital or residential care and enjoy a better quality of life, he said.

Tunstall is currently developing Chinese versions of both its PNC call management software and ICP patient management system.

The partners are launching two Smart Care Monitoring Centres based in Shanghai and Qingdao. www.tunstallhealthcare.com.au www.revlis.com.tw